The Sun Has Not Set On Protests Of Civilian Agency Task Orders
Client Alert | 1 min read | 06.14.11
In Technatomy Corp. (June 14, 2011), GAO ruled that the sunset provision contained in the 2008 amendments to the Federal Acquisition Streamlining Act ("FASA") for GAO's civilian task order protest jurisdiction applied not only to the provisions granting GAO exclusive jurisdiction over protests of task order awards in excess of $10 million, but to the entirety of subsection 41 U.S.C.§ 253j(e), and, therefore, GAO's jurisdiction over protests of task or delivery orders essentially reverted to the jurisdiction that previously existed under CICA (pre-FASA), under which there is no jurisdictional distinction between protests of awards of contracts and of task orders. The net effect is that any task order award of any value pursuant to a civilian agency contract is subject to the protest jurisdiction of GAO and possibly of the Court of Federal Claims, to the extent that court agrees with GAO's ruling.
Contacts
Insights
Client Alert | 2 min read | 09.18.25
On September 9, 2025, the U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (HHS) issued a news release announcing an “aggressive[]” “crackdown” on direct-to-consumer pharmaceutical advertising. This release came on the heels of a Presidential Memorandum President Trump issued the same day directing HHS to “ensure transparency and accuracy in direct-to-consumer prescription drug advertisements,” and the FDA to “take action to enforce legal requirements that advertisements for prescription drugs be truthful and not misleading.”
Client Alert | 3 min read | 09.17.25
Client Alert | 4 min read | 09.17.25
Client Alert | 5 min read | 09.16.25
Bucking the Odds: Why Technology Companies Should Embrace Software Patents Today